Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Update on Phase II Bladder Cancer

<< Previous

Bullboard Posts

Next >>

Comment by Oden6570on Jan 15, 2024 8:24am

207 Views

Post# 35826531

RE:RE:Update on Phase II Bladder Cancer

I assume the update now includes the 6 patients they spoke of in recent email !

With the enrolment stage of our NMIBC only approximately 37 patients away and our results improving with every patient, we are very excited for the potential value of our share price.

Our clinical results are best in class and we are optimistic that this will be reflected in our future share price, rewarding our share holders.

Currently we are still waiting on 6 recently treated patients to be added to our results; we wouldn't be surprised with the news to come if positive, provides a significant lift to our share holders value.

<< Previous

Bullboard Posts

Next >>

Report: New, more dangerous malware used in increasing cyberattacks